Anika Therapeutics (ANIK) Net Income Growth (1y) (2011 - 2025)
Anika Therapeutics (ANIK) Net Income Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.93% |
| 10 | Anika Therapeutics | 203.64 Mn | 136.85 Mn | 19.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 92.21% |
| Sep 30, 2025 | 103.01% |
| Jun 30, 2025 | -72.40% |
| Mar 31, 2025 | 64.23% |
| Dec 31, 2024 | -225.08% |
| Sep 30, 2024 | -329.32% |
| Jun 30, 2024 | 188.56% |
| Mar 31, 2024 | 75.29% |
| Dec 31, 2023 | 27.46% |
| Sep 30, 2023 | -56.62% |
| Jun 30, 2023 | 2.57% |
| Mar 31, 2023 | -252.88% |
| Dec 31, 2022 | 213.40% |
| Sep 30, 2022 | -856.34% |
| Jun 30, 2022 | -143.54% |
| Mar 31, 2022 | -203.35% |
| Dec 31, 2021 | -206.49% |
| Sep 30, 2021 | 108.55% |
| Jun 30, 2021 | 184.75% |
| Mar 31, 2021 | -51.01% |